Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ROMVIMZATM safely and effectively. See full prescribing information for ROMVIMZATM. ROMVIMZATM (vimseltinib) capsules, for oral useInitial U.S. Approval: 2025
Medication labelWhy this: Advisory · dailymed-prescription
ROMVIMZA is indicated for treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity.
- generic_name
- vimseltinib
- product_names
- Vimseltinib
- ndc
- 73207-302, 73207-302-41, 73207-302-40, 73207-303, 73207-303-41, 73207-303-40, 73207-304, 73207-304-41, 73207-304-40
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en